April 10, 2012
This video is part of our "Motley Fool Conversations" series, in which Million Dollar Portfolio advisor Charly Travers and Motley Fool Stock Advisor analyst Jason Moser discuss topics around the investing world.
Charly and Jason are bringing you 10 stocks that you can buy and hold for the long term in your IRA to maximize its tax advantages. Charly likes the pharmaceutical companies for their high dividend yields (currently 3% to 4% for most of the global names) and their defensive characteristics (people need to use drugs in all economic environments). Of the world's largest pharmaceuticals, Novartis earns the top grade because of its diversified product portfolio and leadership position in the development of biosimilars.
Every now and again, we come across a stock that has us so excited we can hardly contain our investing enthusiasm. We've uncovered one such pick with so much promise that we've dubbed it "The Motley Fool's Top Stock for 2012." We've created a special free report for investors to uncover this soon-to-be rock star. The report highlights a company that is revolutionizing commerce in Latin America, and you can get instant access to the name of this company by clicking here to download the report now.